L'Oreal Research Laboratories, L'Oreal, 1, Avenue Eugène Schueller, 93600 Aulnay-sous-Bois, France.
Int J Cosmet Sci. 1989 Jun;11(3):129-40. doi: 10.1111/j.1467-2494.1989.tb00502.x.
Synopsis The mutagenicity of aniline was investigated in association with norharman using Aroclor 1254-induced and uninduced liver S9 fractions. The non-mutagenicity of aniline in the Salmonella/mammalian microsome test was also re-examined under various experimental conditions. Aniline caused no increase in the number of revertants per plate in Salmonella typhimurium strains TA1535, TA100, TA1537, TA1538 and TA98 at concentrations of up to 5000 mug/plate. S9 preparations from rat liver, hamster liver, rat spleen, or hamster spleen were all ineffective in activating aniline to a mutagen in tests using various concentrations of S9 in S9 mix. In contrast to the results with aniline alone, mixtures of aniline and norharman were mutagenic in strain TA1538 in the presence of S9 fractions from liver of rats pretreated with Aroclor 1254. The observed mutagenicity decreased as a function of the concentration of S9 in S9 mix. In the presence of uninduced liver S9 preparations, the mutagenicity of the mixture of the two compounds was slight (three-fold).
概要 本研究使用 Aroclor 1254 诱导和未诱导的肝 S9 部分,调查了苯胺与 norharman 的诱变相关性。在各种实验条件下,还重新检查了苯胺在沙门氏菌/哺乳动物微粒体试验中的非致突变性。在浓度高达 5000μg/平板的情况下,苯胺对鼠伤寒沙门氏菌 TA1535、TA100、TA1537、TA1538 和 TA98 菌株的回复突变体数量没有增加。来自大鼠肝、仓鼠肝、大鼠脾或仓鼠脾的 S9 制剂在 S9 混合液中使用各种 S9 浓度的测试中均不能使苯胺激活为诱变剂。与单独使用苯胺的结果相反,在存在用 Aroclor 1254 预处理的大鼠肝 S9 部分的情况下,混合物在 TA1538 菌株中具有致突变性。观察到的致突变性随着 S9 混合物中 S9 浓度的增加而降低。在未诱导的肝 S9 制剂存在下,两种化合物混合物的致突变性较弱(三倍)。